165 related articles for article (PubMed ID: 19019417)
1. LPA receptor 2 mediates LPA-induced endometrial cancer invasion.
Hope JM; Wang FQ; Whyte JS; Ariztia EV; Abdalla W; Long K; Fishman DA
Gynecol Oncol; 2009 Jan; 112(1):215-23. PubMed ID: 19019417
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
Wang FQ; Ariztia EV; Boyd LR; Horton FR; Smicun Y; Hetherington JA; Smith PJ; Fishman DA
Gynecol Oncol; 2010 Apr; 117(1):88-95. PubMed ID: 20056268
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
Wang FQ; Smicun Y; Calluzzo N; Fishman DA
Mol Cancer Res; 2006 Nov; 4(11):831-41. PubMed ID: 17114341
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.
So J; Navari J; Wang FQ; Fishman DA
Gynecol Oncol; 2004 Nov; 95(2):314-22. PubMed ID: 15491751
[TBL] [Abstract][Full Text] [Related]
6. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
7. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Fisher J; Fishman DA
Gynecol Oncol; 2011 Feb; 120(2):247-55. PubMed ID: 21093894
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lysophosphatidic acid receptor-2 expression by RNA interference decreases lysophosphatidic acid-induced urokinase plasminogen activator activation, cell invasion, and migration in ovarian cancer SKOV-3 cells.
Wang GL; Wen ZQ; Xu WP; Wang ZY; Du XL; Wang F
Croat Med J; 2008 Apr; 49(2):175-81. PubMed ID: 18461672
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.
Fishman DA; Liu Y; Ellerbroek SM; Stack MS
Cancer Res; 2001 Apr; 61(7):3194-9. PubMed ID: 11306508
[TBL] [Abstract][Full Text] [Related]
11. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
So J; Wang FQ; Navari J; Schreher J; Fishman DA
Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
[TBL] [Abstract][Full Text] [Related]
12. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
[TBL] [Abstract][Full Text] [Related]
13. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
Dutta S; Wang FQ; Wu HS; Mukherjee TJ; Fishman DA
Gynecol Oncol; 2011 Oct; 123(1):129-37. PubMed ID: 21782227
[TBL] [Abstract][Full Text] [Related]
14. VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Barfield E; Dutta S; Pua T; Fishman DA
Gynecol Oncol; 2009 Dec; 115(3):414-23. PubMed ID: 19765808
[TBL] [Abstract][Full Text] [Related]
15. Loss of lysophosphatidic acid receptor-3 suppresses cell migration activity of human sarcoma cells.
Tanabe E; Kitayoshi M; Yoshikawa K; Shibata A; Honoki K; Fukushima N; Tsujiuchi T
J Recept Signal Transduct Res; 2012 Dec; 32(6):328-34. PubMed ID: 23167620
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
[TBL] [Abstract][Full Text] [Related]
17. Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2.
Kato K; Fukui R; Okabe K; Tanabe E; Kitayoshi M; Fukushima N; Tsujiuchi T
Biochem Biophys Res Commun; 2012 Jan; 417(2):790-3. PubMed ID: 22197817
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor.
Lou L; Chen YX; Jin L; Li X; Tao X; Zhu J; Chen X; Wu S; Ye W; He J; Ding G
J Int Med Res; 2013 Feb; 41(1):55-63. PubMed ID: 23569130
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.
Do TV; Symowicz JC; Berman DM; Liotta LA; Petricoin EF; Stack MS; Fishman DA
Mol Cancer Res; 2007 Feb; 5(2):121-31. PubMed ID: 17314270
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
